Patent 8188231 was granted and assigned to Xencor on May, 2012 by the United States Patent and Trademark Office.
The present invention relates to optimized Fc variants, methods for their generation, Fc polypeptides comprising optimized Fc variants, and methods for using optimized Fc variants.